Tech Company Financing Transactions

Nuclera Funding Round

Nuclera, based in Cambridge, secured $12 million in funding from Elevage Medical Technologies, private investors and British Business Bank.

Transaction Overview

Company Name
Nuclera
Announced On
1/13/2026
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series C
Investors

Elevage Medical Technologies (Lead Investor)

private investors (Lead Investor) (Jonathan Milner)

British Business Bank

G. K. Goh

Proceeds Purpose
The investment will further support the integration of antibody expression and binding validation capabilities into the eProtein Discovery system, enabling in-house multiplex protein screening, characterisation, and expression.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
137 Cambridge Science Park Milton Rd.
Cambridge, CB4 0GD
UK
Phone
Undisclosed
Website
www.nuclera.com
Email Address
[email protected]
Overview
Nuclera is a Bioprinter company that enables life science researchers to accelerate breakthrough improvements in human health through easy access of biomolecules.
Profile
Nuclera LinkedIn Company Profile
Social Media
Nuclera Company Twitter Account
Company News
Nuclera News
Facebook
Nuclera on Facebook
YouTube
Nuclera on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Chen
  Michael Chen LinkedIn Profile  Michael Chen Twitter Account  Michael Chen News  Michael Chen on Facebook
Chief Financial Officer
Jiahao Huang
  Jiahao Huang LinkedIn Profile  Jiahao Huang Twitter Account  Jiahao Huang News  Jiahao Huang on Facebook
Chief Technical Officer
Gordon McInroy
  Gordon McInroy LinkedIn Profile  Gordon McInroy Twitter Account  Gordon McInroy News  Gordon McInroy on Facebook
Vice President
Colin Barnes
  Colin Barnes LinkedIn Profile  Colin Barnes Twitter Account  Colin Barnes News  Colin Barnes on Facebook
Vice President
Eugene Bragin
  Eugene Bragin LinkedIn Profile  Eugene Bragin Twitter Account  Eugene Bragin News  Eugene Bragin on Facebook
VP - Bus. Development
George Easow
  George Easow LinkedIn Profile  George Easow Twitter Account  George Easow News  George Easow on Facebook
VP - Human Resources
Charu Maini
  Charu Maini LinkedIn Profile  Charu Maini Twitter Account  Charu Maini News  Charu Maini on Facebook
VP - Marketing
Kristine Friscino
  Kristine Friscino LinkedIn Profile  Kristine Friscino Twitter Account  Kristine Friscino News  Kristine Friscino on Facebook
VP - R & D
Tobias Ost
  Tobias Ost LinkedIn Profile  Tobias Ost Twitter Account  Tobias Ost News  Tobias Ost on Facebook
VP - R & D
Rick Paolini
  Rick Paolini LinkedIn Profile  Rick Paolini Twitter Account  Rick Paolini News  Rick Paolini on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/13/2026: Haiqu venture capital transaction
Next: 1/13/2026: Mevaldi venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2026. Gaebler Ventures. All rights reserved.